How this startup went from BILLIONS to BROKE

That’s all she wrote… for Theranos, a biotech startup out of Silicon Valley once valued at $9 billion in its heyday. The blood-testing company promised a cheaper, more efficient alternative to medical tests.


Now, no one wants it… and the investment bank working with Theranos contacted over 80 potential buyers – and nothing. The downfall began after Wall Street investigative reporter John Carreyrou exposed the company’s technology and caused Theranos to void two years’ worth of blood tests. I don’t know anything about blood testing, but I do know that is two years down the drain.


99 problems… and regardless of what they are, that is a lot of problems. Last June, former CEO Elizabeth Holmes was indicted on federal wire fraud charges. Additionally, Holmes and former COO Ramesh Balwani allegedly schemed to defraud investors, doctors, and patients out of millions. You can see why these guys collapsed. The company still owes at least $60 million to creditors – I wonder if anyone will accept Schrute Bucks?

Read more